Thakur N, Chakraborty P, Tufariello J, Basler C
bioRxiv. 2024; .
PMID: 39713296
PMC: 11661139.
DOI: 10.1101/2024.12.12.628214.
Cheng L, Rui Y, Wang Y, Chen S, Su J, Yu X
J Biomed Sci. 2024; 31(1):70.
PMID: 39003473
PMC: 11245872.
DOI: 10.1186/s12929-024-01062-1.
Karousis E, Schubert K, Ban N
EMBO J. 2024; 43(2):151-167.
PMID: 38200146
PMC: 10897431.
DOI: 10.1038/s44318-023-00019-8.
Yuan C, Ma Z, Xie J, Li W, Su L, Zhang G
Signal Transduct Target Ther. 2023; 8(1):357.
PMID: 37726282
PMC: 10509267.
DOI: 10.1038/s41392-023-01580-8.
Oh S, Lee S
Front Immunol. 2023; 14:1148727.
PMID: 37261341
PMC: 10228733.
DOI: 10.3389/fimmu.2023.1148727.
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses.
Hurtado-Tamayo J, Requena-Platek R, Enjuanes L, Bello-Perez M, Sola I
Front Cell Infect Microbiol. 2023; 13:1166839.
PMID: 37197199
PMC: 10183600.
DOI: 10.3389/fcimb.2023.1166839.
SARS-CoV-2 viral protein Nsp2 stimulates translation under normal and hypoxic conditions.
Korneeva N, Khalil M, Ghosh I, Fan R, Arnold T, De Benedetti A
Virol J. 2023; 20(1):55.
PMID: 36998012
PMC: 10060939.
DOI: 10.1186/s12985-023-02021-2.
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Kabekkodu S, Chakrabarty S, Jayaram P, Mallya S, Thangaraj K, Singh K
Mitochondrion. 2023; 69:43-56.
PMID: 36690315
PMC: 9854144.
DOI: 10.1016/j.mito.2023.01.005.
Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern.
Capistrano K, Richner J, Schwartz J, Mukherjee S, Shukla D, Naqvi A
Biochim Biophys Acta Mol Basis Dis. 2022; 1869(2):166612.
PMID: 36481486
PMC: 9721271.
DOI: 10.1016/j.bbadis.2022.166612.
Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress.
Liu Z, Fu Y, Huang Y, Zeng F, Rao J, Xiao X
Microbiol Spectr. 2022; 10(6):e0150922.
PMID: 36326498
PMC: 9769937.
DOI: 10.1128/spectrum.01509-22.
Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions.
Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez-Castrellon P, Ma X
MedComm (2020). 2022; 3(3):e154.
PMID: 35923762
PMC: 9340488.
DOI: 10.1002/mco2.154.
Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
Malekinejad Z, Baghbanzadeh A, Nakhlband A, Baradaran B, Jafari S, Bagheri Y
Life Sci. 2022; 306:120809.
PMID: 35841979
PMC: 9278000.
DOI: 10.1016/j.lfs.2022.120809.
Sophoridine Suppresses Herpes Simplex Virus Type 1 Infection by Blocking the Activation of Cellular PI3K/Akt and p38 MAPK Pathways.
Tang Q, Luan F, Yuan A, Sun J, Rao Z, Wang B
Front Microbiol. 2022; 13:872505.
PMID: 35756044
PMC: 9229184.
DOI: 10.3389/fmicb.2022.872505.
Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.
Keskinidou C, Vassiliou A, Dimopoulou I, Kotanidou A, Orfanos S
J Inflamm Res. 2022; 15:3501-3546.
PMID: 35734098
PMC: 9207257.
DOI: 10.2147/JIR.S282695.
Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs).
Valipour M, Irannejad H, Emami S
Drug Dev Res. 2022; 83(6):1246-1250.
PMID: 35706384
PMC: 9350394.
DOI: 10.1002/ddr.21961.
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.
Li X, Zhang Z, Wang Z, Gutierrez-Castrellon P, Shi H
Signal Transduct Target Ther. 2022; 7(1):186.
PMID: 35697684
PMC: 9189267.
DOI: 10.1038/s41392-022-01043-6.
Translational Control of COVID-19 and Its Therapeutic Implication.
Zhang D, Zhu L, Wang Y, Li P, Gao Y
Front Immunol. 2022; 13:857490.
PMID: 35422818
PMC: 9002053.
DOI: 10.3389/fimmu.2022.857490.
Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.
Beeraka N, Sukocheva O, Lukina E, Liu J, Fan R
Rev Med Virol. 2022; 32(5):e2346.
PMID: 35416390
PMC: 9111059.
DOI: 10.1002/rmv.2346.
Conceptual Framework for SARS-CoV-2-Related Lymphopenia.
Rahimmanesh I, Kouhpayeh S, Azizi Y, Khanahmad H
Adv Biomed Res. 2022; 11:16.
PMID: 35386537
PMC: 8977610.
DOI: 10.4103/abr.abr_303_20.
Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses.
Pillai A, JeanPierre A, Mariappan V, Ranganadin P, S R R
Cell Stress Chaperones. 2022; 27(3):189-195.
PMID: 35366756
PMC: 8976658.
DOI: 10.1007/s12192-022-01269-x.